Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
| Name | Authors | DOI | Group |
Summary |
Associated Publications |
RRIDs used | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NEBNext® ARTIC SARS-CoV-2 Companion Kit (Oxford Nanopore Technologies®) E7660 Resource Report Resource Website |
New England Biolabs | DOI:10.17504/protocols.io.btcenite | Coronavirus Method Development Community | This protocol details methods for the NEBNext® ARTIC SARS-CoV-2 Companion Kit (Oxford Nanopore Technologies®), NEB #E7660S/L 24/96 reactions. | New England Biolabs | https://www.neb.com/-/media/nebus/files/manuals/manuale7660.pdf?rev=48c42313dcb64b0dbb16c4bfd1563a27 | 3 | 2021 | New England Biolabs 2021. NEBNext® ARTIC SARS-CoV-2 Companion Kit (Oxford Nanopore Technologies®) E7660. protocols.io https://dx.doi.org/10.17504/protocols.io.btcenite | 2021-04-15 09:16:24 | ||
|
Adapter ligation with AMII Resource Report Resource Website |
Josh Quick | DOI:10.17504/protocols.io.bdp9i5r6 | Diaz-Munoz Lab, Coronavirus Method Development Community, Szentagothai Research Centre Virology | This is a subprotocol for performing adapter ligation with AMII | Pattabiraman C, Habib F, K. HP, Rasheed R, Prasad P, Reddy V, Dinesh P, Damodar T, Hosallimath K, George AK, Reddy NVK, John B, Pattanaik A, Kumar N, Mani RS, Venkataswamy MM, Hameed SKS, G. PKB, Desai A, Vasanthapuram R (2020) Genomic epidemiology reveals multiple introductions and spread of SARS-CoV-2 in the Indian state of Karnataka. PLoS ONE 15(12): e0243412. doi: 10.1371/journal.pone.0243412 | University of Birmingham | http://lab.loman.net/protocols/ | 1 | 2020 | Josh Quick 2020. Adapter ligation with AMII. protocols.io https://dx.doi.org/10.17504/protocols.io.bdp9i5r6 | 2021-04-15 09:16:23 | |
|
NEBNext® ARTIC SARS-CoV-2 Library Prep Kit (Illumina®) (NEB #E7650S/L) Resource Report Resource Website |
Isabel Gautreau | DOI:10.17504/protocols.io.bsy4nfyw | New England Biolabs (NEB), Coronavirus Method Development Community | This protocol is about the NEBNext® ARTIC SARS-CoV-2 Library Prep Kit (Illumina®). | New England Biolabs | https://www.neb.com/-/media/nebus/files/manuals/manuale7650.pdf?rev=f37be6e42b4f486f888f204b83907d3f&hash=69F40067B46B925A7D45F5A6D418095F | 2 | 2021 | Isabel Gautreau 2021. NEBNext® ARTIC SARS-CoV-2 Library Prep Kit (Illumina®) (NEB #E7650S/L). protocols.io https://dx.doi.org/10.17504/protocols.io.bsy4nfyw | 2021-04-15 09:16:50 | ||
|
SensingSelf S1 Rapid Antigen Test (Saliva/Sputum/Stool) Resource Report Resource Website |
Shripal Gandhi, Santo Purnama, Keyur Patel, Praveen Sukumara, Dr Rinu R Ravi | DOI:10.17504/protocols.io.bpudmns6 | Coronavirus Method Development Community, SensingSelfMission, XPRIZE Rapid Covid Testing | Summary:The S1 COVID-19 Rapid Antigen test kit developed by Sensing Self Pte. Ltd. can quickly and qualitatively detect the spike glycoprotein of novel coronavirus (SARS-COV-2) in human saliva/sputum/stool samples. It can be used as an aid for COVID-19 diagnosis.Objective:According to the clinical trial plan, the S1 COVID-19 Rapid Antigen test kit or “test reagent”, is to test saliva/sputum/stool samples from healthy subjects and confirmed COVID-19 patients. Test results are compared with another commercial SARS-COV-2 nucleic acid detection kit with CFDA approval, which is defined as the “gold standard”. The sensitivity, specificity, and total agreement rate are used to evaluate the feasibility of the test reagent in clinical applications.Method:A collection of clinical samples were examined by the S1 COVID-19 Rapid Antigen test kit and the gold standard SARS-COV-2 nucleic acid detection kit in parallel, to calculate the clinical sensitivity, clinical specificity and total agreement rate of the test reagent.Results:Compared to the gold standard, the clinical sensitivity of test reagent reached 90.0%, the clinical specificity reached 100.0%, and the total coincidence rate reached 95.0%.Conclusions:The performance of test reagent has a high agreement rate with the gold standard, proving its good feasibility in diagnosing suspected COVID-19 cases.Some of the sample collection steps were adapted from the published protocol:https://www.protocols.io/view/saliva-collection-and-rna-extraction-for-sars-cov-bh6mj9c6 | Sensing Self Pte Ltd, Singapore, Sensingself pte. ltd., Sensingself pte. ltd., Sensingself pte. ltd., Sensingself pte. ltd. | http://www.sensingself.me | 2 | 2020 | Shripal Gandhi, Santo Purnama, Keyur Patel, Praveen Sukumara, Dr Rinu R Ravi 2020. SensingSelf S1 Rapid Antigen Test (Saliva/Sputum/Stool). protocols.io https://dx.doi.org/10.17504/protocols.io.bpudmns6 | 2021-04-15 09:16:26 | ||
|
HA Filtration of Wastewater for SARS-CoV-2 detection Resource Report Resource Website |
Vbarua , Md Ariful Islam Juel, Neha Mittal, Nick Stark, Cynthia Gibas, jschluet , Mariya Munir | Coronavirus Method Development Community, UNC Charlotte COVID WBE | UNC Charlotte Department of Civil and Environmental Engineering, UNC Charlotte Department of Civil and Environmental Engineering, UNC Charlotte Department of Bioinformatics and Genomics, UNC Charlotte Department of Bioinformatics and Genomics, UNC Charlotte Department of Bioinformatics and Genomics, UNC Charlotte Department of Bioinformatics and Genomics, UNC Charlotte Department of Civil and Environmental Engineering | 1 | 2021 | Vbarua , Md Ariful Islam Juel, Neha Mittal, Nick Stark, Cynthia Gibas, jschluet , Mariya Munir 2021. HA Filtration of Wastewater for SARS-CoV-2 detection. protocols.io https:// | 2021-04-15 09:16:27 | |||||
|
Coronavirus Lateral Flow Assay (LFA) operation protocol Resource Report Resource Website |
peijun he | DOI:10.17504/protocols.io.bksjkwcn | Coronavirus Method Development Community, XPRIZE Rapid Covid Testing, Highfield Diagnostics | Coronavirus Lateral Flow Assay (LFA) operation protocol | Highfield Diagnostics, UK | 1 | 2020 | peijun he 2020. Coronavirus Lateral Flow Assay (LFA) operation protocol. protocols.io https://dx.doi.org/10.17504/protocols.io.bksjkwcn | 2021-04-15 09:16:53 | |||
|
No Sew Face Mask in 10 Steps Resource Report Resource Website |
Julia Borden | DOI:10.17504/protocols.io.be2jjgcn | Coronavirus Method Development Community | This protocol describes how to make a face mask out of a t-shirt in 10 easy steps, no sewing required! | UC Berkeley | 1 | 2020 | Julia Borden 2020. No Sew Face Mask in 10 Steps. protocols.io https://dx.doi.org/10.17504/protocols.io.be2jjgcn | 2021-04-15 09:16:26 | |||
|
1DROP SARS-CoV-2 antigen test Resource Report Resource Website |
Mahe Raccaud, Manon Garzuel, Joerg Ziegler, Luc Gervais | DOI:10.17504/protocols.io.bk38kyrw | Coronavirus Method Development Community, XPRIZE Rapid Covid Testing | Our capillary-driven microfluidic chips automatically detect multiple SARS-CoV-2 antigens after the addition of a few drops of saliva, triggering a cascade of events powered by capillary forces. We integrate biochemical reagents directly on the microfluidic chips, avoiding the need for peripheral equipment for fluid control. Thus, detection of SARS-CoV-2 can be done at the patient’s side by simply adding sample to the chips, with minimal hands-on time, faster results, and increased sensitivity of fluorescence assays. The use of saliva as a sample matrix avoids painful sample-collection procedures and the need for trained medical staff. | 1DROP, 1DROP, 1DROP, 1DROP | 2 | 2020 | Mahe Raccaud, Manon Garzuel, Joerg Ziegler, Luc Gervais 2020. 1DROP SARS-CoV-2 antigen test. protocols.io https://dx.doi.org/10.17504/protocols.io.bk38kyrw | 2021-04-15 09:16:31 | |||
|
Capture and concentration of SARS-CoV-2 and other respiratory viruses from VTM / UTM samples using Magnetic Nanotrap® particles for direct RNA extraction Resource Report Resource Website |
Ben Lepene, Anurag Patnaik, Robert Barclay | Coronavirus Method Development Community, Nanotrap Applications | Ceres Nanosciences, Inc, Ceres Nanosciences, Inc, Ceres Nanosciences, Inc | 1 | 2020 | Ben Lepene, Anurag Patnaik, Robert Barclay 2020. Capture and concentration of SARS-CoV-2 and other respiratory viruses from VTM / UTM samples using Magnetic Nanotrap® particles for direct RNA extraction. protocols.io https:// | 2021-04-15 09:16:35 | |||||
|
Kit-free automated RNA extraction for SARS-CoV-2 testing Resource Report Resource Website |
Efthymios Fidanis, Maria Greco, Amelia Edwards, Margaret Crawford, Laura Cubitt, Sophia Ward, Robert Goldstone, Nnenna Kanu, James MacRae, Michael Hubank, Jerome Nicod | DOI:10.17504/protocols.io.bfb5jiq6 | Coronavirus Method Development Community, Crick COVID-19 Consortium | Purpose of examination / Clinical relevanceAt the end of 2019, several pneumonia cases were reported in Wuhan, China and the pathogen was confirmed as a new viral strain. World Health organization has named the newly identified coronavirus as 2019-nCoV, also known as SARS-Cov-2. The disease developed into a dangerous pandemic, posing major challenges to the NHS. Although more research is necessary to better understand the virus, in response to the emergency, simple and rapid testing is essential to identify the virus in infected individuals. This will aid the implementation of efficient interventions to contain the spread, and distinguish healthcare workers who have been infected, and are required to self-isolate, from those showing similar symptoms but which are not 2019-nCoV associated. The latter category may continue to work, alleviating stress on hard-pressed healthcare resources. 2019-nCoV is an RNA virus, and the diagnostic tests detect viral RNA in swabs from patient airways using a reverse transcriptase PCR assay. Samples are submitted to HSL, an accredited reporting laboratory, and transferred to the Crick for testing. The first step of the process is sample receipt at the Crick. This SOP describes the extraction of RNA from the inactivated sample.Principles of ExaminationThis procedure involves extraction of COVID-19 RNA from inactivated virus samples that have been aliquoted into plates. This protocol follows a method developed in-house that is automated on the Biomek FX liquid handling platform. All reagents and buffers prepared in house are batch tested and certified. | Aitken, J., Ambrose, K., Barrell, S. et al. Scalable and robust SARS-CoV-2 testing in an academic center. Nat Biotechnol (2020). https://doi.org/10.1038/s41587-020-0588-y | The Francis Crick Institute, The Francis Crick Institute, The Francis Crick Institute, The Francis Crick Institute, The Francis Crick Institute, The Francis Crick Institute, The Francis Crick Institute, University College London, The Francis Crick Institute, The Institute of Cancer Research, The Royal Marsden Hospital, The Francis Crick Institute | https://doi.org/10.1038/s41587-020-0588-y | 1 | 2020 | Efthymios Fidanis, Maria Greco, Amelia Edwards, Margaret Crawford, Laura Cubitt, Sophia Ward, Robert Goldstone, Nnenna Kanu, James MacRae, Michael Hubank, Jerome Nicod 2020. Kit-free automated RNA extraction for SARS-CoV-2 testing. protocols.io https://dx.doi.org/10.17504/protocols.io.bfb5jiq6 | 2021-04-15 09:16:56 | |
|
Financing and Insurance (Part 12 of Phase 3 study of Vaccine Candidate for COVID-19) Resource Report Resource Website |
Chris Ockenhouse, Chris Gast, Renee Holt, Jorge Flores | DOI:10.17504/protocols.io.bj59kq96 | Coronavirus Method Development Community, PATH | This is Part 12 of "Phase 3 randomized, double-blinded, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of Vaccine Candidate against COVID-19 in adults > 18 years of age"This generic Phase 3 protocol was developed by the PATH team with support of the Bill and Melinda Gates Foundation. The aim of the collection is to share recommended best practices in designing and implementing a Phase 3 study of a COVID-19 vaccine candidate. As Phase 3 trials of different Vaccine Candidates proceed around the world, following the same protocols will ensure consistency and comparability of the Phase 3 trial results.Please note that this is an evolving document, to be versioned and updated, based on community feedback and new data. | Center for Vaccine Innovation and Access, PATH (Washington D.C. and Seattle, Washington), Center for Vaccine Innovation and Access, PATH (Washington D.C. and Seattle, Washington), Center for Vaccine Innovation and Access, PATH (Washington D.C. and Seattle, Washington), Center for Vaccine Innovation and Access, PATH (Washington D.C. and Seattle, Washington) | 1 | 2020 | Chris Ockenhouse, Chris Gast, Renee Holt, Jorge Flores 2020. Financing and Insurance (Part 12 of Phase 3 study of Vaccine Candidate for COVID-19). protocols.io https://dx.doi.org/10.17504/protocols.io.bj59kq96 | 2021-04-15 09:16:36 | |||
|
SARS-CoV-2 NCBI assembly submission protocol: GenBank Resource Report Resource Website |
Ruth Timme, Heather Blankenship, Erin Young, Emma Griffiths, Duncan MacCannell, Stacia Wyman | DOI:10.17504/protocols.io.bg2tjyen | GenomeTrakr, Coronavirus Method Development Community, PHA4GE | PURPOSE: This protocol covers the steps for submitting a SARS-CoV-2 assembly to NCBI's GenBankFor new submitters, there's quite a bit of groundwork that needs to be established before a laboratory can start its first data submission. We recommend that one person in the laboratory take a few days to get everything set up in advance of when you expect to do your first data submission. Two protocols cover the PHA4GE guidance for SARS-CoV-2 submission to NCBI (Raw sequence data, metadata, and assemblies). If you need a pipeline for frequent or large volume submissions, follow Step 1 in the SARS-CoV-2 NCBI submission protocol: SRA, BioSample, and BioProject to get your NCBI submission environment established, then contact [email protected] to set up an account for submitting through the API. These protocols cover submission using NCBI's Submission Portal web-interface.Complete in order (1 then 2):1. SARS-CoV-2 NCBI submission protocol: SRA, BioSample, and BioProjectStep-by-step instructions for establishing a new NCBI laboratory submission account and for creating and linking a new BioProject to an existing umbrella effort.Submit SARS-CoV-2 raw data to SRA (Sequence Read Archive) and metadata to BioSample.2. SARS-CoV-2 NCBI assembly submission protocol: GenBank (included protocol) Required: established BioProject and BioSamplesSubmit SARS-CoV-2 consensus sequences to NCBI GenBank, linking to existing BioProject, BioSamples, and raw data.2. SARS-CoV-2 NCBI assembly submission protocol: GenBank (included protocol) Required: established BioProject and BioSamples | US Food and Drug Administration, Michigan Department of Health and Human Services, Utah Public Health Laboratoraty, University of British Columbia, Centers for Disease Control and Prevention, Innovative Genomics Institute, UC Berkeley | 1 | 2020 | Ruth Timme, Heather Blankenship, Erin Young, Emma Griffiths, Duncan MacCannell, Stacia Wyman 2020. SARS-CoV-2 NCBI assembly submission protocol: GenBank. protocols.io https://dx.doi.org/10.17504/protocols.io.bg2tjyen | 2021-04-15 09:16:59 | |||
|
A protocol for rapid detection of the 2019 novel coronavirus SARS-CoV-2 using CRISPR diagnostics: SARS-CoV-2 DETECTR Resource Report Resource Website |
Mammoth Biosciences, James P. Broughton, Wayne Deng, Clare L. Fasching, Jasmeet Singh, Charles Y. Chiu, Janice S. Chen | DOI:10.17504/protocols.io.bcmtiu6n | Coronavirus Method Development Community | ***DISCLAIMER: This protocol has not been approved by the FDA and should not be used as a clinical diagnostic***IntroductionGiven the global health emergency, rapid transmission, and severe respiratory disease associated with the outbreak of the 2019 novel coronavirus (SARS-CoV-2), Mammoth Biosciences has reconfigured our DETECTR platform to rapidly and accurately detect SARS-CoV-2 using a visual lateral flow strip format within 30 minutes from sample to result. To ensure specificity of detection, we selected a high-fidelity CRISPR detection enzyme and designed sets of gRNAs that can either 1) differentiate SARS-CoV-2 or 2) provide multi-coronavirus strain detection. SARS-CoV-2 DETECTR couples CRISPR detection with isothermal pre-amplification using primers based on protocols validated by the US Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO). Currently in the United States, the CDC SARS-CoV-2 real-time RT-PCR diagnostic panel has a laboratory turnaround time of approximately 4-6 hours, with results that can be delayed for >24 hours after sample collection due to shipping requirements. In addition, these tests are only available in CDC-designated public health laboratories certified to perform high-complexity testing. Mammoth is working to enable point of care testing (POCT) solutions that can be deployed in areas at greatest risk of transmitting SARS-CoV-2 infection, including airports, emergency departments, and local community hospitals, particularly in low-resource countries. Leveraging an “off-the-shelf” strategy to enable practical solutions within a short time frame, we describe here a protocol that is fast ( AB1Specifications2Targets● N-gene (SARS-CoV-2 specific) ● E-gene (SARS-CoV, bat-SARS-like-CoV, and SARS-CoV-2 coronaviruses) ● RNase P (human sample control)3Limit of detection70-300 copies/μl inputAcknowledgements: We thank Vikram Joshi, Nefeli Tsaloglou and Xin Miao for advice and helpful discussions in the preparation of this whitepaper.Conflicts of Interest: JPB, CLF, JS and JSC are employees of Mammoth Biosciences, CYC is on the Scientific Advisory Board of Mammoth Biosciences, and JSC is a co-founder of Mammoth Biosciences. JPB, CLF, JS, CYC and JSC are co-inventors on CRISPR-related technologies. | [Mammoth Biosciences, Inc., South San Francisco, California, USA], Mammoth Biosciences, Inc., South San Francisco, California, USA, Department of Laboratory Medicine, University of California, San Francisco, California, USA; UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA, Mammoth Biosciences, Inc., South San Francisco, California, USA, Mammoth Biosciences, Inc., South San Francisco, California, USA, Department of Laboratory Medicine, University of California, San Francisco, California, USA; UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA; Department of Medicine, Division of Infectious Diseases, University of California, San Francisco, California, USA, Mammoth Biosciences, Inc., South San Francisco, California, USA | https://mammoth.bio/2020/02/15/white-paper-a-protocol-for-rapid-detection-of-sars-cov-2-using-crispr-sars-cov-2-detectr/ | 1 | 2020 | Mammoth Biosciences, James P. Broughton, Wayne Deng, Clare L. Fasching, Jasmeet Singh, Charles Y. Chiu, Janice S. Chen 2020. A protocol for rapid detection of the 2019 novel coronavirus SARS-CoV-2 using CRISPR diagnostics: SARS-CoV-2 DETECTR. protocols.io https://dx.doi.org/10.17504/protocols.io.bcmtiu6n | 2021-04-15 09:16:40 | ||
|
Mask-Based Covid-19 testing system using Exhaled Breath Condensate Resource Report Resource Website |
John Daniels | Coronavirus Method Development Community, Front Line Technologies, XPRIZE Rapid Covid Testing, Team Exhaled Breath Condensate | DiagMetrics, Inc. (fka Kinaptic, LLC) | https://diagmetrics.com/ | 2 | 2020 | John Daniels 2020. Mask-Based Covid-19 testing system using Exhaled Breath Condensate. protocols.io https:// | 2021-04-15 09:16:40 | ||||
|
Probe-based target enrichment of SARS-CoV-2 Resource Report Resource Website |
Mariateresa De Cesare | DOI:10.17504/protocols.io.bd5di826 | Coronavirus Method Development Community, COG-UK | Viral RNA library prep using SMARTer Stranded Total RNA-Seq Kit v2 – Pico Input Mammalian followed by a probe-based bait capture (SeqCap, Roche and xGen, IDT) to generate tagged enriched viral libraries from total RNA that retain directionality in the library. The SMARTer Stranded kit uses random primers, tailed with Illumina Read1 sequence, to start reverse transcription, and a Template Switching Oligo (TSO) to add Read2 sequence at the 3’ of the synthesized cDNA. The 1st stranded cDNA is then amplified using Indexed primers to generate in one step 2nd strand cDNA and complete tagged Illumina libraries. Pooled libraries undergo target enrichment using custom virus-specific biotinylated probes to capture cDNA derived from viral RNA present in the sample.This method has been optimized for large scale viral sequencing projects, and up to 2 x 96-well RNA plates can be prepped in parallel.The protocol follows “Option 2 (without fragmentation)” workflow of the kit User Manual for library preparation, with ¼ of the recommended reaction volume for denaturation and cDNA synthesis, and ½ for PCR, all steps done in 384-well plates.NOTE: the kit contains a Ribodepletion PCR-based module not used in this protocol, so PCR reagents are in excess and a higher volume for PCR can be used safely without depleting the kit of reagents unevenly.The absence of an RNA fragmentation step coupled with more stringent cleanups (at 0.68x) generates libraries with longer insert size, therefor this protocol is only to be used on RNA samples of high quality, and unnecessary freeze-thaw of the RNA MUST be avoided. As the RNA extracted from plasma/swabs is below the detection level for QC, if in doubt about the quality of the RNA provided, proceed with library preparation and pooling, but check the size of the libraries before cleanup of the pool as the 0.68X beads ratio recommended in this protocol would remove most of the library if the starting RNA is of lower quality.To maximize RNA input and improve sensitivity of the assay, an RNA concentration step at the start of the procedure has been added, though not necessary to generate libraries.NOTE: the kit contains a Ribodepletion PCR-based module not used in this protocol, so PCR reagents are in excess and a higher volume for PCR can be used safely without depleting the kit of reagents unevenly.The absence of an RNA fragmentation step coupled with more stringent cleanups (at 0.68x) generates libraries with longer insert size, therefor this protocol is only to be used on RNA samples of high quality, and unnecessary freeze-thaw of the RNA MUST be avoided. As the RNA extracted from plasma/swabs is below the detection level for QC, if in doubt about the quality of the RNA provided, proceed with library preparation and pooling, but check the size of the libraries before cleanup of the pool as the 0.68X beads ratio recommended in this protocol would remove most of the library if the starting RNA is of lower quality.To maximize RNA input and improve sensitivity of the assay, an RNA concentration step at the start of the procedure has been added, though not necessary to generate libraries. | Welcome Centre for Human Genetics, University of Oxford | 1 | 2020 | Mariateresa De Cesare 2020. Probe-based target enrichment of SARS-CoV-2. protocols.io https://dx.doi.org/10.17504/protocols.io.bd5di826 | 2021-04-15 09:16:42 | |||
|
SalivaDirect: RNA extraction-free SARS-CoV-2 diagnostics Resource Report Resource Website |
Chantal Vogels, Doug E. Brackney, Chaney Kalinich, Isabel Ott, Nathan Grubaugh, Anne Wyllie | DOI:10.17504/protocols.io.bh6jj9cn | Coronavirus Method Development Community | The first section of this protocol details recommendations for collecting saliva for SARS-CoV-2 detection, either by self-collection or healthcare worker-assisted collection.The second section details an extraction-free method for preparation of saliva samples for SARS-CoV-2 RNA detection. This involves the addition of proteinase K to reduce saliva viscosity, followed by a heating step to inactivate the proteinase K before RT-qPCR testing.The third section describes a dualplex RT-qPCR assay for high-throughput SARS-CoV-2 diagnostics. The CDC_N1 (N1) primer/probe set targets the SARS-CoV-2 nucleocapsid gene, and is shown to be sensitive and specific. The human RNase P (RP) primer/probe set is included as an internal sample control - detection of RP at PCR cycle threshold (CT) Version 2 includes: Optimized thermocycler conditionsLocally validated alternative options for Proteinase K, RT-qPCR master mix, and thermocyclersUse of 8-strip tubes for sample processing step, due to contamination issues in 96-well plates. | Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Department of Environmental Sciences The Connecticut Agricultural Experiment Station; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Department of Epidemiology of Microbial Diseases, Yale School of Public Health | https://covidtrackerct.com/about-salivadirect/ | 2 | 2020 | Chantal Vogels, Doug E. Brackney, Chaney Kalinich, Isabel Ott, Nathan Grubaugh, Anne Wyllie 2020. SalivaDirect: RNA extraction-free SARS-CoV-2 diagnostics. protocols.io https://dx.doi.org/10.17504/protocols.io.bh6jj9cn | 2021-04-15 09:16:46 | ||
|
Freeze-drying (Lyophilization) and manufacturing of Corona Detective assay Resource Report Resource Website |
Guy Aidelberg, Rachel Aronoff | DOI:10.17504/protocols.io.bpv4mn8w | Coronavirus Method Development Community, Reclone.org (The Reagent Collaboration Network), XPRIZE Rapid Covid Testing, Guy Aidelberg | A protocol for freeze-drying (Lyophilization) of CoronaDetective tests, and more generally any QUASR RT-LAMP reaction.The amounts here are for one 96 well standard PCR plate and for reactions This can be scaled for any amount and size. | CRI (Center for research and interdisciplinarity) Paris, Hackuarium | https://app.jogl.io/project/181 | 2 | 2020 | Guy Aidelberg, Rachel Aronoff 2020. Freeze-drying (Lyophilization) and manufacturing of Corona Detective assay. protocols.io https://dx.doi.org/10.17504/protocols.io.bpv4mn8w | 2021-04-15 09:16:49 | ||
|
Cecret Workflow Protocol for SARS-CoV-2 Assembly and Lineage Classification Resource Report Resource Website |
Erin Young, TOAST CDC, OAMD CDC | Coronavirus Method Development Community | Utah Public Health Laboratory, Centers for Disease Control and Prevention | https://github.com/StaPH-B/staphb_toolkit | 1 | 2021 | Erin Young, TOAST CDC, OAMD CDC 2021. Cecret Workflow Protocol for SARS-CoV-2 Assembly and Lineage Classification . protocols.io https:// | 2021-04-15 09:16:50 | ||||
|
HolographicDiagnostics: Automated Virus Binding Assay Resource Report Resource Website |
Rushna Quddus, Kaitlynn Snyder, Lauren Altman, Laura Philips, David G. Grier, Andrew D. Hollingsworth, Kent Kirshenbaum | DOI:10.17504/protocols.io.bkpgkvjw | Coronavirus Method Development Community, Grier Group, HolographicDiagnostics, XPRIZE Rapid Covid Testing | This protocol describes the steps required to perform a holographic immunoassay for SARS-CoV-2 whole virus particles. The assay uses an xSight holographic particle characterization instrument (Spheryx, Inc.) to monitor the diameter of specifically functionalized probe beads. The diameter of the beads increases by a few nanometers as targets bind to the surface. xSight detects and reports this change, yielding an estimate for the concentration of analytes in the sample. The method for holographic immunoassays (applied to antibody binding assays) is described inY. Zagzag, M. F. Soddu, A. D. Hollingsworth and D. G. Grier, Holographic molecular binding assays, Scientific Reports 10, 1932 (2020) and K. Snyder, R. Quddus, A. D. Hollingsworth and K. Kirshenbaum, Holographic Immunoassays: Direct Detection of Antibodies Binding to Colloidal Spheres, submitted for publication (2020). | New York University, New York University, New York University, Spheryx Inc, New York University, New York University, New York University | 1 | 2020 | Rushna Quddus, Kaitlynn Snyder, Lauren Altman, Laura Philips, David G. Grier, Andrew D. Hollingsworth, Kent Kirshenbaum 2020. HolographicDiagnostics: Automated Virus Binding Assay. protocols.io https://dx.doi.org/10.17504/protocols.io.bkpgkvjw | 2021-04-15 09:17:01 | |||
|
COVID-19 ARTIC v3 Illumina library construction and sequencing protocol - tailed method Resource Report Resource Website |
DNA Pipelines R&D, Benjamin Farr, Diana Rajan, Emma Betteridge, Lesley Shirley, Michael Quail, Naomi Park, Nicholas Redshaw, Iraad Bronner, Louise Aigrain, Scott Goodwin, Scott Thurston, Stefanie Lensing, James Bonfield, Keith James, Nicholas Salmon, Charlotte Beaver, Rachel Nelson, David K. Jackson, Alex Alderton, Ian Johnston | DOI:10.17504/protocols.io.bky5kxy6 | Coronavirus Method Development Community, COG-UK | This SOP describes the procedure for generating cDNA from SARS-CoV-2 viral nucleic acid extracts and subsequently producing 400nt amplicons tiling the viral genome using V3 nCov-2019 primers (ARTIC) in multiplex PCR. Illumina-compatible sequencing libraries are then made directly from these amplicons in a second PCR step, obviating the need for conventional library preparation. The products of these PCRs are then equivolume pooled and quantitated, prior to sequencing on the Illumina NovaSeq.It is an adaptation of the COVID-19 ARTIC v3 amplicon protocol which can be found here:https://www.protocols.io/view/covid-19-artic-v3-illumina-library-construction-an-bibtkannBoth the above protocols were adapted from the nCov-2019 sequencing protocol: https://www.protocols.io/view/ncov-2019-sequencing-protocol-bbmuik6w | Wellcome Sanger Institute, Wellcome Sanger Institute, Wellcome Sanger Institute, Wellcome Sanger Institute, Wellcome Sanger Institute, Wellcome Sanger Institute, Wellcome Sanger Institute, Wellcome Sanger Institute, Wellcome Sanger Institute, Wellcome Sanger Institute, Wellcome Sanger Institute, Wellcome Sanger Institute, Wellcome Sanger Institute, Wellcome Sanger Institute, Wellcome Sanger Institute, Wellcome Sanger Institute, Wellcome Sanger Institute, Wellcome Sanger Institute, Wellcome Sanger Institute, Wellcome Sanger Institute, Wellcome Sanger Institute | 1 | 2020 | DNA Pipelines R&D, Benjamin Farr, Diana Rajan, Emma Betteridge, Lesley Shirley, Michael Quail, Naomi Park, Nicholas Redshaw, Iraad Bronner, Louise Aigrain, Scott Goodwin, Scott Thurston, Stefanie Lensing, James Bonfield, Keith James, Nicholas Salmon, Charlotte Beaver, Rachel Nelson, David K. Jackson, Alex Alderton, Ian Johnston 2020. COVID-19 ARTIC v3 Illumina library construction and sequencing protocol - tailed method. protocols.io https://dx.doi.org/10.17504/protocols.io.bky5kxy6 | 2021-04-15 09:16:49 |
Can't find your Protocol?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. If you want to find a specific protocol and you know the DOI of the protocol already, it's easier to enter a DOI to search. You can refine the search results using Facets on the left side of the search results page. If you are on the table view, you can also search in a specific column by clicking the column title and enter the keywords.
If you still could not find your protocol in the search results, please help us by adding it into the system — it's easy. Create and publish your protocols at Protocols.io.
Welcome to the dkNET Resources search. From here you can search through a compilation of resources used by dkNET and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that dkNET has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on dkNET then you can log in from here to get additional features in dkNET such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into dkNET you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
The NIDDK Information Network (dkNET) serves the needs of basic and clinical investigators by providing seamless access to large pools of data and research resources relevant to the mission of The National Institute of Diabetes Digestive and Kidney Diseases (NIDDK). dkNET is hosted at University of California San Diego, and is supported by NIH NIDDK grant U24DK097771.
Email: info_at_ dknet.org
